Preview Mode Links will not work in preview mode

Coming Together for Sexual Health


Mar 8, 2021

On Jan 21, 2021, the FDA approved Cabenuva, the first once-monthly injectable HIV treatment for adults. Dr. Kelly Johnson, a fellow in infectious diseases and in sexually transmitted diseases at the University of California, San Francisco, explains the implications of this new treatment and how it affects the 1.2 million Americans living with HIV. Dr Johnson is a physician focused on HIV at San Francisco General Hospital Ward 86.